نتایج جستجو برای: rfsh

تعداد نتایج: 244  

2008
Fatma A. Aletebi F. A. Aletebi

The use of progesterone for luteal support in stimulated cycles for in-vitro fertilization is well established. However, the benefits of the addition of estradiol are still controversial. The aim of this study was to compare ongoing pregnancy rates in patients stimulated with recombinant follicle stimulating hormone and gonadotrophin releasing hormone antagonist for in vitro fertilization, who ...

2012
Hala Gomaa Robert F Casper Navid Esfandiari Paul Chang Yaakov Bentov

BACKGROUND To compare the outcome of IVF cycles in women receiving controlled ovarian stimulation with recFSH or recFSH plus low dose hCG. METHODS A retrospective case control study, performed at a private practice affiliated with an academic institute. Patients were infertile women who were treated with IVF/ICSI and controlled ovarian stimulation in a long GnRH agonist protocol using either ...

Journal: :Human reproduction 2005
G Ragni W Vegetti A Riccaboni B Engl C Brigante P G Crosignani

BACKGROUND During IVF or ICSI cycles, ovarian hyperstimulation syndrome (OHSS) is a major problem. The aim of this prospective, multicentre, comparative study (using historical controls) was to assess the efficacy of a GnRH antagonist protocol in preventing OHSS in selected patients who had experienced OHSS or had been at risk of OHSS in their previous IVF/ICSI attempt. METHODS AND RESULTS Pa...

2015
SALVATORE GIZZO ALESSANDRA ANDRISANI MARCO NOVENTA SERENA MANFÈ ALESSANDRA OLIVA MICHELE GANGEMI GIOVANNI BATTISTA NARDELLI GUIDO AMBROSINI

Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin‑releasing hormone (GnRH)‑antagonist (ant) treatment is used the optimal administration timing and daily dose of rLH remains to be elucidated. The ...

Journal: :Human reproduction 2006
C B Lambalk A Leader F Olivennes M R Fluker A Nyboe Andersen J Ingerslev Y Khalaf C Avril J Belaisch-Allart R Roulier B Mannaerts

BACKGROUND This study was designed to assess whether the use of ganirelix in women undergoing stimulated IUI could prevent the occurrence of premature LH rises and luteinization (LH+progesterone rises). METHODS Women of infertile couples, diagnosed with unexplained or male factor infertility, were randomized to receive either ganirelix (n=103) or placebo (n=100) in a double-blind design. All ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید